6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Respiratory viruses, a common microbiological finding in neutropenic children with fever

      research-article
      a , * , b , c , a , a , a , d , d , d , e , b , a , a
      Journal of Clinical Virology
      Elsevier B.V.
      AdV, adenovirus, B19, erythrovirus B19, HboV, bocavirus, CMV, cytomegalovirus, CRP, C-reactive protein, EBV, Epstein-Barrvirus, EV, enterovirus, G+, Gram positive bacteria, G−, Gram negative bacteria, HKU1, coronavirus HKU1, MPV, humant metapneumovirus, HRV, humant rhinovirus, KIPyV, KI polyomavirus, NL63, coronavirus NL63, NPA, nasopharyngeal aspirate, OC43, coronavirus OC43, PIV3, parainfluenzaevirus 3, RSV, respiratory syncytial virus, URTS, upper respiratory tract symptoms, WUPyV, WU polyomavirus, Viral infections, Neutropenia, Fever, Pediatrics

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Febrile neutropenia is a common complication in children undergoing chemotherapy for malignancies. A microbial agent is only identified in 15–30% of the fever episodes and corresponds mostly to bacterial findings.

          Objective

          To investigate viral infections as possible etiologic agents in episodes of febrile neutropenia.

          Study design

          Nasopharyngeal aspirates (NPAs) from patients presenting with neutropenic fever at two pediatric oncology wards in Sweden and Australia were analyzed with a conventional virus-diagnostic approach and RT-PCR. Coupled blood samples were analyzed for the detection of CMV, EBV, adenovirus and erythrovirus. Bacterial blood culture was performed routinely.

          Results

          Conventional virus-diagnostic approach coupled to routinely performed bacterial analyzes revealed an infectious agent in 29% compared to 60% when using PCR. By adding PCR, a viral pathogen was detected in 46% of the NPAs and in 4% of the blood samples collected. In half of the patients with bacteremia, respiratory tract viruses were co-detected.

          Conclusion

          Respiratory viruses were frequently detected in NPAs suggesting a significant role of viral infections in children presenting with neutropenic fever. The meaning of these findings needs to be further evaluated but has the potential to individualize infection treatment and to reduce the extensive use of antibiotics in immunocompromised children with neutropenia.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Respiratory syncytial viral infection in children with compromised immune function.

          For 10 winters, 608 children five years old or younger who were hospitalized with respiratory syncytial virus (RSV) infection were prospectively studied to evaluate the relation between their immune status and the severity of their infection. Forty-seven had been immunocompromised by chemotherapy, steroid therapy, or a primary immunodeficiency disorder. Among the immunocompromised children, those receiving chemotherapy for cancer and those with immunodeficiency disease had more severe RSV disease, with pneumonia occurring at all ages, and a higher mortality rate. Children receiving long-term steroid therapy did not appear to have more severe clinical manifestations than normal children. Viral shedding, however, was significantly greater and more prolonged in the children receiving steroid therapy, and particularly in those receiving chemotherapy or with an immunodeficiency disease. Giant-cell pneumonia was documented in one child with leukemia. Over half the immunocompromised children acquired the RSV infection nosocomially. These findings indicate that children receiving chemotherapy for cancer and those with immunodeficiency disease are at risk for complicated or fatal infections from RSV and should be considered for antiviral and other therapies as they become available. Efforts should also be made to protect compromised children if hospitalization cannot be avoided.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Serial viral infections in infants with recurrent respiratory illnesses.

            To better understand the viral aetiology of recurrent and prolonged illnesses, nasal secretions were prospectively collected from 285 infants at increased risk of developing asthma. Of these, 27 infants had recurrent (at least five) moderate-to-severe respiratory illnesses (MSIs). The viral aetiology of the 150 MSIs and 86 scheduled visits was analysed by molecular diagnostics. The demographic and clinical data were compared with infants who had 0-4 MSIs. Frequently ill infants had higher exposure to other children and more wheezing illnesses than less symptomatic children. Viruses were detected in 136 (91%) out of 150 MSIs, 14 (67%) out of 21 mild illnesses and 29 (45%) out of 65 asymptomatic visits. Human rhinovirus was the most common aetiological agent (61, 43 and 35% in MSIs, mild illnesses and asymptomatic visits, respectively). Mixed viral infections were generally associated with more severe illnesses (27, 0 and 5%, respectively). Among the 27 frequently ill infants, only eight (5.3%) out of 150 MSIs were prolonged (> or =2 weeks duration). Considering all samples, detection of the same virus strain > or =2 weeks apart was unusual (5.3% of all 244 positive findings). Human rhinovirus infections occur early, pervasively and repetitively in these high-risk infants. Infants with prolonged or recurrent respiratory illnesses most often have a series of infections rather than persistent infection with one virus strain.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Development and implementation of a molecular diagnostic platform for daily rapid detection of 15 respiratory viruses

              Abstract Acute respiratory tract infections are caused by a large number of viruses. Diagnostic methods have until recently been available only for a limited number of these viruses. With the objective to achieve sensitive assays for all respiratory viruses, a rational workflow in the laboratory, and a short turn‐around time, a real‐time PCR diagnostic platform for daily rapid detection of 15 respiratory viruses was developed. The system was evaluated on 585 stored nasopharyngeal aspirates from hospitalized children. Previous analysis by immunofluorescence and virus isolation identified viruses in 37% of the samples while the new PCR diagnostic panel detected 57% virus positive samples. The new platform was introduced in the laboratory in October 2007 and has then fully replaced the standard immunofluorescence assay for rapid detection of viruses and virus isolation. J. Med. Virol. 81:167–175, 2009. © 2008 Wiley‐Liss, Inc.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Clin Virol
                J. Clin. Virol
                Journal of Clinical Virology
                Elsevier B.V.
                1386-6532
                1873-5967
                6 January 2010
                March 2010
                6 January 2010
                : 47
                : 3
                : 234-237
                Affiliations
                [a ]Unit of Infectious Diseases, Department of Medicine, Solna, and Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
                [b ]Paediatric Oncology Unit, The Children's Hospital at Westmead, Sydney, Australia
                [c ]Childhood Cancer Unit, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
                [d ]Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, and Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
                [e ]The Tumour Bank, The Children's Hospital at Westmead, Sydney, Australia
                Author notes
                [* ]Corresponding author at: Center for Molecular Medicine, L8:01, Karolinska University Hospital, Solna, S-171 76 Stockholm, Sweden. Tel.: +46 8 51776748; fax: +46 8 51771806. anna.lindblom@ 123456ki.se
                Article
                S1386-6532(09)00567-8
                10.1016/j.jcv.2009.11.026
                7108298
                20056482
                838da722-2906-480b-b9d9-f99a85b4c138
                Copyright © 2009 Elsevier B.V. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 24 June 2009
                : 24 November 2009
                : 29 November 2009
                Categories
                Article

                Microbiology & Virology
                adv, adenovirus,b19, erythrovirus b19,hbov, bocavirus,cmv, cytomegalovirus,crp, c-reactive protein,ebv, epstein-barrvirus,ev, enterovirus,g+, gram positive bacteria,g−, gram negative bacteria,hku1, coronavirus hku1,mpv, humant metapneumovirus,hrv, humant rhinovirus,kipyv, ki polyomavirus,nl63, coronavirus nl63,npa, nasopharyngeal aspirate,oc43, coronavirus oc43,piv3, parainfluenzaevirus 3,rsv, respiratory syncytial virus,urts, upper respiratory tract symptoms,wupyv, wu polyomavirus,viral infections,neutropenia,fever,pediatrics

                Comments

                Comment on this article